Literature DB >> 12428283

Systemic endotoxemia during chronic viral hepatitis.

A S Sozinov1.   

Abstract

Incidence and severity of systemic endotoxemia in patients with chronic viral hepatitis B and C were studied using the limulus test. Healthy subjects and patients with acute viral hepatitis B and C comprised reference groups. The incidence of "physiological" systemic endotoxemia in healthy subjects was 31.3%, while in chronic hepatitis systemic endotoxemia was found in 69-84% patients and it was more severe in this case. A significant correlation was revealed between systemic endotoxemia with virus replication and the degree of basic clinical and laboratory signs in patients with chronic viral hepatitis B.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12428283     DOI： 10.1023/a:1015546821875

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN： 0007-4888            Impact factor:   0.804


  14 in total

1.  The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases.

Authors:  João-Bruno Soares; Pedro Pimentel-Nunes; Roberto Roncon-Albuquerque; Adelino Leite-Moreira
Journal:  Hepatol Int       Date:  2010-10-21       Impact factor: 6.047

2.  Inhibitions of NF-κB and TNF-α result in differential effects in rats with acute on chronic liver failure induced by d-Gal and LPS.

Authors:  Fan Yang; Xun Li; Li-Kun Wang; Lu-Wen Wang; Xiao-Qun Han; Hong Zhang; Zuo-Jiong Gong
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

3.  Bacterial Translocation and Risk of Liver Cancer in a Finnish Cohort.

Authors:  Baiyu Yang; Jessica L Petrick; Jake E Thistle; Ligia A Pinto; Troy J Kemp; Hao Quang Tran; Andrew T Gewirtz; Tim Waterboer; Veronika Fedirko; Mazda Jenab; Barry I Graubard; Stephanie J Weinstein; Demetrius Albanes; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-02       Impact factor: 4.254

4.  Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats.

Authors:  Lu-Wen Wang; Li-Kun Wang; Hui Chen; Cheng Fan; Xun Li; Can-Ming He; Zuo-Jiong Gong
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

5.  Toll-like receptors as targets in chronic liver diseases.

Authors:  A Mencin; J Kluwe; R F Schwabe
Journal:  Gut       Date:  2009-05       Impact factor: 23.059

6.  Blockade of high-mobility group box-1 ameliorates acute on chronic liver failure in rats.

Authors:  Xun Li; Li-Kun Wang; Lu-Wen Wang; Xiao-Qun Han; Fan Yang; Zuo-Jiong Gong
Journal:  Inflamm Res       Date:  2013-04-17       Impact factor: 4.575

7.  Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.

Authors:  Jessica Nyström; Jenny Stenkvist; Amanda Häggblom; Ola Weiland; Piotr Nowak
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

8.  Probiotic as a novel treatment strategy against liver disease.

Authors:  Abbas Ali Imani Fooladi; Hamideh Mahmoodzadeh Hosseini; Mohammad Reza Nourani; Soghra Khani; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2013-02-25       Impact factor: 0.660

9.  Dynamic changes of lipopolysaccharide levels in different phases of acute on chronic hepatitis B liver failure.

Authors:  Calvin Pan; Yurong Gu; Wei Zhang; Yubao Zheng; Liang Peng; Hong Deng; Youming Chen; Lubiao Chen; Sui Chen; Min Zhang; Zhiliang Gao
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

10.  Microbial translocation in chronic liver diseases.

Authors:  Marilia Rita Pinzone; Benedetto Maurizio Celesia; Michele Di Rosa; Bruno Cacopardo; Giuseppe Nunnari
Journal:  Int J Microbiol       Date:  2012-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.